Glycopyrrolate Injection
Product Images NDC 75834-196

This is a description of Glycopyrrolate Injection, USP available in 25x 1 mL Single Dose Vials. It contains 0.2mg of Glycopyrrolate, USP and 0.9% Benzyl Alcohol, NF as a preservative. It is not meant for use in newborns and should only be administered via the intramuscular or intravenous route. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide. Usual dosage should be referred to in the accompanying descriptive literature. The product should be stored between 20°C-25°C (68°F-77°F) as per USP Controlled Room Temperature guidelines.*

This is a description of a medication labeled NDC 75834-196-10, containing Glycopyrrolate. It is available in a 10 x 20 mL multiple dose vial, with each mL containing 0.2 mg of Glycopyrrolate, USP, and Benzyl Alcohol, NF (preservative) 0.9%. It is used for intramuscular and intravenous use only, and usual dosage should be determined by accompanying literature. It is manufactured by Nivagen Pharmaceuticals, Inc, with a toll-free number listed for contact information. The medication should be stored between 20°C-25°C (68°F-77°F). The lot number is also provided.*

This is a description of a medication called Glycopyrrolate, which is an injection that should not be used. It is contained in a 20 mL multiple-dose vial labeled 'B only' and contains Glycopyrrolate, Benzyl Alcohol, and Water for Injection. The medication is for intramuscular and intravenous use and has a usual dosage, which can be found in the accompanying descriptive literature. The medication is stored at a temperature of 20°C-26°C (66°F-77°F), and the manufacturer is NIVAGEN. The product number is 75834-196-01, and it was made in Taiwan. The text seems to be missing the expiration date, listed as "Exp".*

This is a description of a medication called Glycopyrrolate, available in 25x2mL single dose vials. It is an injection solution to be used for both intramuscular and intravenous purposes. Each mL contains 0.2mg of Glycopyrrolate, Benzyl Alcohol as a preservative, and Water for Injection. The pH of the solution is adjusted with hydrochloric acid and/or sodium hydroxide when necessary. The recommended dosage is not mentioned and should be referred to the accompanying descriptive literature. The medication should be stored at controlled room temperature, between 20°C-25°C (88°F-77°F).*

This is a medication called Glycopyrrolate, which is available in 2mL single-dose vials for intramuscular and intravenous use. It contains 0.2mg of Glycopyrrolate and is dissolved in water for an injection. The pH is adjusted with hydrochloric acid and/or sodium hydroxide. It may contain a preservative called Benzyl Alcohol. The manufacturer is Hivagen Pharmaceuticals in Sacramento, US, and the product's NDC code is 75834-194-01.*

This text contains information about Glycopyrrolate Injection, USP, which comes in a 25 x 5 mL Multiple Dose Vials B only. The medication contains Benzyl Alcohol and should not be used in newborns. Each mL of the medication contains Glycopyrrolate, USP 0.2 mg, Water for Injection, USP q.5., Benzyl Alcohol, NF (preservative) 0.9%, and pH adjusted, when necessary, with hydrochloric acid and/or sodium hydroxide. The usual dosage should be referred to the accompanying literature. Additionally, the medication should be stored at 20°C-25°C (68°F-77°F). The medication is manufactured for Nivagen Pharmaceuticals, Inc in Sacramento, CA, USA. The text also includes a toll-free number for inquiries and mentions that it is made in Taiwan.*

This is a description of Glycopyrrolate injectable solution. It is a 5 mL vial for intravenous or intramuscular use only. It contains 0.2 mg of USP Glycopyrrolate and Benzyl Alcohol as a preservative. Each vial is pH adjusted with hydrochloric acid and/or sodium hydroxide. The recommended dosage is available in the accompanying literature. It should be stored at 20°C-25°C. Nivagen Pharmaceutical manufactures it. Their contact number is provided for further inquiries.*